Submit Your Manuscript

JAPST is a focused platform for pharmaceutical development and technology research. Use the steps below to confirm scope fit, prepare your files, and submit efficiently.

Journal at a glance

ISSN: 2328-0182 | DOI prefix: 10.14302/issn.2328-0182 | License: CC BY 4.0 | Open access publishing

Submission routes

Choose the submission method that best fits your workflow. All routes are reviewed by the editorial office and recorded in the same system.

ManuscriptZone tips

If you submit through ManuscriptZone, complete your profile with current affiliation, ORCID ID, and subject expertise. This improves reviewer matching and reduces follow up requests during processing.

Keep your login details active so you can respond to revision requests quickly. The platform also stores decision letters and reviewer comments for easy reference.

Choose the right article type

Selecting the correct article type speeds up editorial screening and ensures reviewers apply the right evaluation criteria. Review the options below before submission.

Scope fit: we prioritize manuscripts that

JAPST is a pharmaceutical science and technology journal. Before submission, confirm that your manuscript provides a concrete pharmaceutics deliverable.

• Formulation strategy with characterization data, stability evidence, and performance results.
• Delivery performance results that connect platform design to bioavailability or therapeutic effect.
• Validated analytical methods, dissolution profiles, or PAT workflows for quality control.
• Stability or PK evidence linked to formulation or processing decisions.
• Manufacturing scale up, QbD, or quality engineering with defined controls and outcomes.
• Translational manufacturability that supports clinical or commercial readiness.

We do not prioritize purely clinical pharmacotherapy studies or purely biological research without a pharmaceutical science or technology contribution.

Minimum technical evidence

To maintain a strong pharmaceutical development focus, submissions should include clear technical evidence. The following signals strengthen scope fit and reduce screening delays.

• Formulation design rationale supported by physicochemical characterization.
• Delivery performance data with comparative benchmarks or control formulations.
• Validated analytical methods for identity, purity, potency, or release.
• Stability data that supports storage recommendations or shelf life decisions.
• Manufacturing process description with critical quality attributes and controls.
• Evidence of scalability or translational manufacturing feasibility.

Prepare your manuscript

Follow the Instructions for Author for formatting, reporting standards, and required documentation. Submissions that align with journal scope and format move faster through screening.

Use clear headings, consistent units, and standardized terminology across text, tables, and figures. Include enough methodological detail for replication, and state how your data supports the development or technology claim.

Manuscript structure guidance

Well structured manuscripts move through review faster. Use the outline below for most research articles and adapt as needed for review or methods papers.

• Title, abstract, and keywords that highlight the pharmaceutics deliverable.
• Introduction with a clear development or technology gap.
• Materials and methods with validation and reproducibility details.
• Results with clear figures, tables, and statistical support.
• Discussion linking findings to formulation, delivery, or manufacturing impact.
• Conclusion focused on translational or scale up relevance.

Review articles should describe search strategy, inclusion criteria, and synthesis approach. Methods papers should include validation parameters and practical implementation guidance for laboratory or production teams.

Figures, tables, and data quality

High quality visuals improve reviewer confidence and reduce revision cycles. Ensure that all figures and tables are self explanatory, labeled clearly, and referenced in the manuscript text.

• Provide resolution suitable for publication and include units on axes.
• Use consistent symbols, abbreviations, and naming across all panels.
• Include statistical details, sample sizes, and error bars where relevant.
• Submit raw or supplemental datasets when they support validation.

Data availability and supplemental files

Provide a clear data availability statement and indicate where readers can access supporting datasets, protocols, or code. When data cannot be shared, explain the limitation and the steps used to verify results.

Supplemental files should include extended methods, validation details, or additional figures that strengthen reproducibility. Use descriptive file names and reference each item in the manuscript.

Cover letter guidance

A concise cover letter helps the editorial team evaluate scope fit quickly. Include the manuscript title, article type, and a summary of the pharmaceutics deliverable.

• Explain how the work advances formulation, delivery, analytics, or manufacturing.
• Highlight novelty compared to existing approaches.
• Confirm that the manuscript is original and not under review elsewhere.

Author details and ORCID

Provide complete author names, affiliations, and contact details for each contributor. Consistent formatting helps indexing services and prevents delays during production.

Include ORCID IDs where available and specify author contributions, funding sources, and corresponding author responsibilities. If you use multiple institutions, indicate primary affiliation clearly to support accurate metadata and discoverability.

Submission checklist

• Title and abstract reflect a pharmaceutical science or technology contribution.
• Results include formulation, delivery, analytical, stability, or manufacturing data.
• Methods and validation details are sufficient for replication.
• Figures are labeled clearly and match the manuscript text.
• References follow the journal format and include DOI where available.
• All authors have approved the final manuscript and order.

If you use reporting guidelines or checklists, include them as supplemental files to speed editorial review.

Common causes of delay

Most delays occur when submissions do not clearly demonstrate a pharmaceutical development contribution or omit critical documentation. Address these items to keep your review on track.

• Missing validation details for analytical methods or assays.
• Insufficient stability or release data to support conclusions.
• Scope misalignment with purely clinical or biology only focus.
• Incomplete ethics statements or missing author disclosures.

Pre submission inquiry

If you are uncertain about scope fit, send a short summary and key figures to the editorial office. We will confirm whether the manuscript aligns with JAPST focus before you submit.

Email [email protected] and include the manuscript title, article type, and one paragraph describing the pharmaceutics deliverable.

Review and decision workflow

1. Editorial screening for scope fit, completeness, and ethical compliance.
2. Assignment to subject experts for single blind peer review.
3. First decision with reviewer comments and revision guidance.
4. Revisions reviewed by editors and, if needed, reviewers.
5. Final acceptance and production for online publication.

We prioritize clear communication and provide updates at each stage so authors can plan project timelines with confidence.

Revisions and resubmissions

When revisions are requested, respond to each reviewer point clearly and highlight all changes in the manuscript. Provide a point by point response to help editors assess improvements efficiently.

If your manuscript is declined for scope reasons, you may submit a revised version only if the pharmaceutics deliverable has been strengthened and aligned with JAPST focus. Timely resubmission helps maintain review momentum.

After acceptance

Accepted manuscripts enter production for copyediting, formatting, and final proof review. Articles are published open access with DOIs and indexed metadata that improves discoverability across search and research platforms.

• Professional copyediting and layout for readability.
• Author proof review to confirm technical accuracy.
• Rapid online publication and permanent DOI assignment.

Accurate titles, abstracts, and keywords improve indexing and help readers identify pharmaceutics contributions quickly.

Article processing charges

JAPST is open access, and article processing charges support editorial management, peer review coordination, and production. We consider waiver and discount requests for authors with demonstrated need.

Review the Article Processing Charges page for details and eligibility guidance. If your institution needs invoice support or waiver confirmation, contact the editorial office before acceptance. This helps prevent production delays.

Author rights and licensing

Published articles are distributed under the CC BY 4.0 license, allowing reuse with attribution. This supports funder mandates and enables broad dissemination of your research.

For licensing details, visit the Copyright License page.

Language and editorial support

If you need help polishing language or presentation, we offer a dedicated Language Editing Service. This service strengthens clarity and improves the chances of a smooth review cycle.

For pre submission questions, scope checks, or technical queries, contact [email protected].

Ready to submit?

Share your pharmaceutical science and technology research with a global audience.